investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Biology ↓7.95   Biopharma ↑0.46   Gene and cell ↑1.25 «See more»   RNA ↑8.02   Medicine ↑8.02   Immunology ↑50

RNA stock segment: trending tickers

ADTX ADiTx Therapeutics, Inc. - Common Stock 50% 50% 0 + Immunology, RNA, Medicine
+ My List
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock -0.33% up -0.49% 0.16 + Biopharma, RNA, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/0000879407-26-000037-index.htm
8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer)
+ My List
BNTC Benitec Biopharma Inc. - Common Stock 1.25% down 1.92% -0.67 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm
8-K - Benitec Biopharma Inc. (0001808898) (Filer)
+ My List
LIFE aTyr Pharma, Inc. - Common Stock -7.95% down -7.89% -0.06 + Biology, RNA, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1339970/000133997026000030/0001339970-26-000030-index.htm
8-K - aTYR PHARMA INC (0001339970) (Filer)
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares 2.13% 2.13% 0 + Medicine, Biotechnology, Disease: Eye , RNA

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1612940/000110465926069450/0001104659-26-069450-index.htm
6-K - ProQR Therapeutics N.V. (0001612940) (Filer)
+ My List
TWST Twist Bioscience Corporation - Common Stock 3.01% down 5.42% -2.41 + Biotechnology, RNA, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1581280/000158128026000040/0001581280-26-000040-index.htm
10-Q - Twist Bioscience Corp (0001581280) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.